Meissner, Torsten B.

Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9

Mandal, P. K., Ferreira, L. M. R., Collins, R., Meissner, T. B., Boutwell, C. L., Friesen, M., Vrbanac, V., Garrison, B. S., Stortchevoi, A., Bryder, D., et al. (2014) · Cell stem cell

CRISPR and Genetic EngineeringCAR-T cell therapy research

Cited by 475

NLR family member NLRC5 is a transcriptional regulator of MHC class I genes

Meissner, T. B., Li, A., Biswas, A., Lee, K.-H., Liu, Y.-J., Bayir, E., Iliopoulos, D., van den Elsen, P. J., & Kobayashi, K. S. (2010) · Proceedings of the National Academy of Sciences

Immunotherapy and Immune ResponsesImmune Response and Inflammation

Cited by 447

Stable inhibitory activity of regulatory T cells requires the transcription factor Helios

Kim, H.-J., Barnitz, R. A., Kreslavsky, T., Brown, F. D., Moffett, H., Lemieux, M. E., Kaygusuz, Y., Meissner, T., Holderried, T. A. W., Chan, S., et al. (2015) · Science

T-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

Cited by 441

Generation of hypoimmunogenic human pluripotent stem cells

Han, X., Wang, M., Duan, S., Franco, P. J., Kenty, J. H.-R., Hedrick, P., Xia, Y., Allen, A., Ferreira, L. M. R., Strominger, J. L., et al. (2019) · Proceedings of the National Academy of Sciences

Pluripotent Stem Cells ResearchCRISPR and Genetic Engineering

Cited by 363

Genome-edited human pluripotent stem cell–derived macrophages as a model of reverse cholesterol transport—brief report

Gupta, R. M., Meissner, T. B., Cowan, C. A., & Musunuru, K. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology

Cholesterol and Lipid MetabolismPluripotent Stem Cells Research

Cited by 37